1 Institute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany.
2 Department of Medical Genetics, Ankara City Hospital, Ankara Yildirim Beyazit University, Ankara, Turkey.
3 Vanderbilt Genetics Institute, Department of Cell and Developmental Biology, Vanderbilt University Medical Cente, Nashville, United States of America.
4 Department of Biology, Concordia University, Montreal, Canada.
5 Department of Chemistry and Biochemistry, Concordia University, Montreal, Canada.
6 Stem Cell Unit, Department of Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany.
7 Biological and Medical Research Center (BMFZ), Genomics & Transcriptomics L, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine University, Düsseldorf, Germany.
8 Institute of Human Genetics, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine University, Düsseldorf, Germany.
9 Berlin Institute of Health at Charité-Universi

As a major component of intracellular trafficking, the coat protein complex II (COPII) is indispensable for cellular function during embryonic development and throughout life. The four SEC24 proteins (A-D) are essential COPII components involved in cargo selection and packaging. A human disorder corresponding to alterations of SEC24 function is currently only known for SEC24D. Here, we report that biallelic loss of SEC24C leads to a syndrome characterized by primary microcephaly, brain anomalies, epilepsy, hearing loss, liver dysfunction, anemia, and cataracts in an extended consanguineous family with four affected individuals. We show that knockout of sec24C in zebrafish recapitulates important aspects of the human phenotype. SEC24C-deficient fibroblasts display alterations in the expression of several COPII components as well as impaired anterograde trafficking to the Golgi, indicating a severe impact on COPII function. Transcriptome analysis revealed that SEC24C deficiency also impacts the proteasome and autophagy pathways. Moreover, a shift in the N-glycosylation pattern and deregulation of the N-glycosylation pathway suggest a possible secondary alteration of protein glycosylation, linking the described disorder with the congenital disorders of glycosylation.